Aphelion

Nectero Medical Announces Completion of $96M Series D Financing

Retrieved on: 
Thursday, April 11, 2024
Research, Medical Devices, Surgery, FDA, Clinical Trials, Biotechnology, General Health, Pharmaceutical, Health, Science, Aphelion, Collagen, PGG, Phase, Investment, Safety, NDA, Food, AAA, Elastin, Patient, Boston Scientific, Medicine, General partnership, Venture round, Norwest Venture Partners, Breakthrough therapy, Medical device

Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, today announced the closing of its $96 million Series D financing round.

Key Points: 
  • Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, today announced the closing of its $96 million Series D financing round.
  • Upon completion of the Series D financing, Dr. Zack Scott, of Norwest Venture Partners, and Dr. Alan Davis, of BioStar Capital, have joined the Nectero Medical Board of Directors.
  • In January 2024, Nectero Medical initiated a Phase II/III clinical trial (stAAAble) to investigate the safety and efficacy of the Nectero EAST System in patients with infrarenal abdominal aortic aneurysms (AAAs), maximum diameter 3.5 – 5.0cm.
  • “We are honored and excited to be the lead investor in the Series D financing to fund the efforts necessary to bring the Nectero EAST System to market,” said Dr. Zack Scott, General Partner, Norwest Venture Partners.

Biolinq Raises $58 Million to Advance Wearable Biosensors Through Pivotal Trial for Metabolic Health Using Precision Microsensor Technology

Retrieved on: 
Thursday, April 4, 2024
Research, Other Health, Pharmaceutical, Technology, Medical Devices, Clinical Trials, Science, Nanotechnology, Biotechnology, Wearables, Mobile Technology, Health, Diabetes, Other Science, Aphelion, AXA, Taisho Pharmaceutical, Skin, Bleeding, Needle, Multimedia, FDA, Incorporated, Silicon

J.P. Morgan served as placement agent to Biolinq in connection with the financing.

Key Points: 
  • J.P. Morgan served as placement agent to Biolinq in connection with the financing.
  • “Our technology approach enables access to a coveted, metabolically active compartment of the skin for biosensing without the use of introducer needles or bleeding,” said Rich Yang, CEO, Biolinq.
  • “Companies that disrupt entire industries often don’t originate from a single discipline,” said Rick Gerson, Chairman of Alpha Wave Global.
  • “Biolinq has attracted leading experts in biosensor development, consumer electronics design, proprietary materials science, software engineering and semiconductor manufacturing to build a new category of biowearables.

Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and Sectoral Asset Management

Retrieved on: 
Monday, March 4, 2024
Aphelion, Sector, FDA, ISC, EQT, Dysphagia, Pneumonia, Stroke, Entrepreneurship, Risk, Conference, Health Economics, Saliva, Patient, Brain, Patient capital, Economics, Mortality, Research, Pharmaceutical industry

The combined European and United States investment syndicate was led by EQT Life Sciences, and co-led by Sectoral, with new investors British Patient Capital, Northern Gritstone and Aphelion/Cardeation Capital also joining the round.

Key Points: 
  • The combined European and United States investment syndicate was led by EQT Life Sciences, and co-led by Sectoral, with new investors British Patient Capital, Northern Gritstone and Aphelion/Cardeation Capital also joining the round.
  • Patients with swallowing dysfunction (dysphagia) are unable to safely or effectively eat, drink, or manage their own saliva.
  • Dysphagia can often lead to life threatening complications such as pneumonia and is also associated with substantially higher healthcare costs.
  • Drew Burdon, Partner at EQT Life Sciences, said: "Dysphagia is a severe medical condition that affects countless patients in hospital.

Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and Sectoral Asset Management

Retrieved on: 
Monday, March 4, 2024
Aphelion, Sector, FDA, ISC, EQT, Dysphagia, Pneumonia, Stroke, Entrepreneurship, Risk, Conference, Health Economics, Saliva, Patient, Brain, Patient capital, Economics, Mortality, Research, Pharmaceutical industry

The combined European and United States investment syndicate was led by EQT Life Sciences, and co-led by Sectoral, with new investors British Patient Capital, Northern Gritstone and Aphelion/Cardeation Capital also joining the round.

Key Points: 
  • The combined European and United States investment syndicate was led by EQT Life Sciences, and co-led by Sectoral, with new investors British Patient Capital, Northern Gritstone and Aphelion/Cardeation Capital also joining the round.
  • Patients with swallowing dysfunction (dysphagia) are unable to safely or effectively eat, drink, or manage their own saliva.
  • Dysphagia can often lead to life threatening complications such as pneumonia and is also associated with substantially higher healthcare costs.
  • Drew Burdon, Partner at EQT Life Sciences, said: "Dysphagia is a severe medical condition that affects countless patients in hospital.

Satellite Software Innovator Antaris Announces Close of $4.2 Million Seed Funding Round to Accelerate Development of Software Solutions for Space

Retrieved on: 
Tuesday, August 9, 2022
Aphelion, Janus, Multimedia, Industry, CEO, ZES, Technology, Janusz I of Warsaw, Research, LOS, Ye Olde Space Bande, View, Stone Key Partners, Planet Labs, Entrepreneurship, Renewable energy, Communications satellite, Television, New Space, Carta Brava Jr.

LOS ALTOS, Calif., Aug. 9, 2022 /PRNewswire/ -- Antaris, the software platform provider for space, announced the company has closed a $4.2 million seed round of funding led by Acequia Capital and Possible Ventures. The round also includes investment from leading space tech investors Lockheed Martin Ventures, HCVC, E2MC and Ananth Technologies.

Key Points: 
  • The round also includes investment from leading space tech investors Lockheed Martin Ventures, HCVC, E2MC and Ananth Technologies.
  • Antaris, the software platform for space, announces close of seed funding round with leading technology investors.
  • "We created Antaris to make space easy," said Tom Barton, Co-Founder and CEO of Antaris.
  • "Our platform dramatically simplifies the way satellites are designed, built and operated, and we're excited to accelerate our development efforts with this new funding round.

Moving Analytics Raises $20M to Scale Cardiovascular Telehealth Programs in Underserved Communities

Retrieved on: 
Wednesday, July 13, 2022
Technology, Fitness & Nutrition, Telemedicine, Virtual Medicine, Cardiology, Practice Management, Internet, General Health, Health, Science, Other Science, Aphelion, Stanford University, Friends, Program, Awareness, Analytics, HITRUST, Color, Partnership, Patient, CEO, WXOS, Mortality, COVID-19, Cardiovascular disease, Entrepreneurship, Depression, Death, Cardiology, Citibank, Kaiser Permanente, Woman, Aftercare, Quality of life, Hospital, Adoption, Hypertension, New York State Department of Health, Mayo Clinic, Fortis Healthcare, Pharmaceutical industry, Medicine, Investment

Moving Analytics , the leading telehealth provider of cardiovascular prevention programs, today announced it has raised a $20 million Series A financing round.

Key Points: 
  • Moving Analytics , the leading telehealth provider of cardiovascular prevention programs, today announced it has raised a $20 million Series A financing round.
  • In addition to the raise, Jason Robart, Co-Founder & Managing Partner at Seae Ventures, and Nick Pappas, Partner at Philips Ventures, will join Moving Analytics Board of Directors.
  • Moving Analytics is the leading national telehealth provider of remote cardiac rehab and cardiovascular prevention programs.
  • Moving Analytics programs were developed in partnership with Stanford University and are based on more than 30 years of published research.

Aphelion Aerospace Completes Rocket Engine Development Test and Continues with Launch Vehicle Design for Suborbital Launch Demonstration

Retrieved on: 
Friday, April 22, 2022
Aphelion, Research, Satellite city, Transport, Technology, Apsis, Jet fuel, Communications satellite, Helios

The test activity was conducted with support from Aphelion Aerospace's propulsion R&D partner, Frontier Astronautics, at their facility near Chugwater, WY.

Key Points: 
  • The test activity was conducted with support from Aphelion Aerospace's propulsion R&D partner, Frontier Astronautics, at their facility near Chugwater, WY.
  • This work will culminate in fabrication and qualification of low-cost flight-ready rocket engines for the company's Helios nanosatellite launch vehicle.
  • The Helios launch system is a low-cost, dedicated nanosatellite launch vehicle designed to provide low-cost, on-demand launch services for commercial and government customers.
  • To learn more about Aphelion Aerospace, please visit their website at https://aphelionaerospace.com and StartEngine campaign page at https://www.startengine.com/aphelion-aerospace .

Aphelion Aerospace Secures Contract of up to $10M in CubeSat Products for Global STEM Project

Retrieved on: 
Friday, April 22, 2022
Aphelion, CubeSat, Master service agreement, STEM School Highlands Ranch, Lockheed Martin, AIAA, STEM, R, AMSAT, Education, Student, Apsis, MSA, Multimedia, Communications satellite, Tourism, Orbit

This MSA is a 5-year contract for CubeSat simulators, balloon launched CubeSats, and rocket launched CubeSats that can operate in space.

Key Points: 

Aphelion Aerospace secures investment from The Mercury Group, Founder Advisors, and Richtr Financial Studio

Retrieved on: 
Friday, April 1, 2022
Aphelion, Robotics, Program Manager, Deutsche Telekom, NASA, Investment, Data science, Skunk Works, Product management, Hearing, Air force, CTO, CEO, Business administration, Spacecraft, Artificial intelligence, Technology, Mercury, United States Air Force, Lockheed, SpaceX, Program, Jet Propulsion Laboratory, Transport, Communications satellite, Apsis

Aphelion announced today that it has received significant investment from strategic investors including The Mercury Group, Founder Advisors, and Richtr Financial Studio.

Key Points: 
  • Aphelion announced today that it has received significant investment from strategic investors including The Mercury Group, Founder Advisors, and Richtr Financial Studio.
  • Ben feels excited to back Aphelion with investment and plans to continue supporting Aphelion along its journey to bring this new technology to market.
  • James Graham, CEO of Richtr Financial Studio, is an ardent supporter of Aphelion's possibilities.
  • Richtr Financial Studio supports Aphelion with financial and accounting services.

Aphelion Aerospace secures investment from The Mercury Group, Founder Advisors, and Richtr Financial Studio

Retrieved on: 
Friday, April 1, 2022
Aphelion, Robotics, Program Manager, Deutsche Telekom, NASA, Investment, Data science, Skunk Works, Product management, Multimedia, Hearing, Air force, CTO, CEO, Business administration, Spacecraft, Artificial intelligence, Technology, Mercury, United States Air Force, Lockheed, SpaceX, Program, Jet Propulsion Laboratory, Financial adviser, Transport, Apsis

Aphelion announced today that it has received significant investment from strategic investors including The Mercury Group, Founder Advisors, and Richtr Financial Studio.

Key Points: 
  • Aphelion announced today that it has received significant investment from strategic investors including The Mercury Group, Founder Advisors, and Richtr Financial Studio.
  • Aphelion Aerospace announce investment from The Mercury Group of North Carolina and Founder Advisors of Colorado.
  • Ben feels excited to back Aphelion with investment and plans to continue supporting Aphelion along its journey to bring this new technology to market.
  • Richtr Financial Studio supports Aphelion with financial and accounting services.